SCHEMBL60704

SCHEMBL60704

[CH]1CCC(c2ccccc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 5/20 0.56
SIGMAR1 Q99720 2/20 0.56
GRIN2B Q13224 3/20 0.44
DRD2 P14416 1/20 0.44
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
CYP2D6 P10635 3/20 0.42
CYP2C19 P33261 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C1 Q04828 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16048164 0.91 SLC18A3 (0.48) SLC18A3SIGMAR1CYP2D6CYP2C19CYP1A2
SCHEMBL385172 0.87 SLC18A3 (0.48) SLC18A3SIGMAR1GRIN2BDRD2GAA
SCHEMBL8716435 0.86 RAB9A (0.56) SLC18A3SIGMAR1KMT2ASMN1; SMN2
SCHEMBL41763 0.83
SCHEMBL190417 0.83 SLC18A3 (0.67) SLC18A3SIGMAR1GRIN2BDRD2GAA
Benzene SCHEMBL23070411 0.80 SLC18A3 (0.64) SLC18A3SIGMAR1GRIN2BDRD2GAA
Hydrogen Peroxide SCHEMBL2353767 0.80 SLC18A3 (0.64) SLC18A3SIGMAR1GRIN2BCYP2D6CYP2C19
Ammonia Solution, Strong SCHEMBL3932661 0.80 SLC18A3 (0.64) SLC18A3SIGMAR1GRIN2BDRD2GAA
Hydrochloric Acid SCHEMBL29241797 0.80 SLC18A3 (0.64) SLC18A3SIGMAR1GRIN2BDRD2GAA
SCHEMBL11315420 0.78 SLC18A3 (0.50) SLC18A3SIGMAR1GRIN2BDRD2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2081 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169403-B9 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-07-03 EP claimed
EP-3169403-B1 ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES PROTAGONIST THERAPEUTICS INC (US) 2024-02-14 EP claimed
US-20230348387-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2023-11-02 US claimed
EP-3688124-B1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP claimed
CN-116802179-A BCL-2 inhibitors 百济神州有限公司 2023-09-22 CN claimed
US-20230174486-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2023-06-08 US claimed
US-20230159522-A1 BCL-2 INHIBITOR BEONE MEDICINES I GMBH (CH) 2023-05-25 US claimed
CN-115867534-A Non-lysosomal glucosylceramidase inhibitors and uses thereof 阿勒克图治疗公司 2023-03-28 CN claimed
EP-4146623-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF Alectos Therapeutics Inc. (CA) 2023-03-15 EP claimed
EP-4146624-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF Alectos Therapeutics Inc. (CA) 2023-03-15 EP claimed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO claimed
JP-2002532613-A 2002-10-02 JP claimed
WO-2002018515-A1 LIQUID CRYSTAL MIXTURE CLARIANT INTERNATIONAL LTD. (DE) 2002-03-07 WO claimed
EP-1147162-A1 FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE Clariant GmbH (DE) 2001-10-24 EP claimed
US-6265402-B1 ANTIINFLAMMATORY AGENTS NIKKEN CHEMICALS CO., LTD. (JP) 2001-07-24 US claimed
WO-2000036054-A1 FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE CLARIANT GMBH (DE) 2000-06-22 WO claimed
EP-0924204-A1 2-PHENYLMORPHOLIN-5-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Nikken Chemicals Company, Limited (JP) 1999-06-23 EP claimed
US-4954489-A ACYLATION BEECHAM GROUP P.L.C. (GB) 1990-09-04 US claimed
EP-0337643-A2 6-Substituted acrylamido penicillanic acid derivatives, preparation and use BEECHAM GROUP PLC (GB) 1989-10-18 EP claimed
US-3998834-A ANALGESICS JANSSEN PHARMACEUTICA N.V. (BE) 1976-12-21 US claimed